InvestSMART

Burgundy Diamond Mines Limited (ASX: BDM) - Announcements

- Current share price for BDM : $0.017

ASX company news and announcements for Burgundy Diamond Mines Limited (BDM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Burgundy Diamond Mines Limited (BDM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Burgundy Diamond Mines Limited (BDM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Burgundy Diamond Mines Limited (BDM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Half Yearly Report 21 Feb 2007 10:12AM $0.300 $0.017 fallen by 94.33%
$24 Commitments Test Entity - Second Quarter Report 25 Jan 2007 9:46AM $0.325 $0.017 fallen by 94.77%
$24 BioDiem receives 4th milestone of US$1m for flu vaccine 29 Nov 2006 10:21AM $0.310 $0.017 fallen by 94.52%
$24 Commitments Test Entity - First Quarter Report 27 Oct 2006 10:08AM $0.255 $0.017 fallen by 93.33%
$24 Supplementary Prospectus 18 Sep 2006 10:44AM $0.285 $0.017 fallen by 94.04%
$24 Preliminary Final Report 30 Aug 2006 4:15PM $0.350 $0.017 fallen by 95.14%
$24 Cooperative Research & Development Agreement 30 Aug 2006 4:12PM $0.410 $0.017 fallen by 95.85%
$24 Trading Halt 30 Aug 2006 10:08AM n/a $0.017 n/a
$24 Disclosure Document 7 Aug 2006 10:08AM $0.261 $0.017 fallen by 93.49%
$24 Proposed two for three entitlement issue 7 Aug 2006 10:01AM $0.261 $0.017 fallen by 93.49%
$24 Commitments Test Entity - Fourth Quarter Report 27 Jul 2006 2:35PM n/a $0.017 n/a
$24 First patients complete BDM-E phase II study 17 Jul 2006 10:19AM $0.271 $0.017 fallen by 93.72%
$24 Moves into commercialisation phase for BDM-I feed additive 14 Jul 2006 10:17AM $0.271 $0.017 fallen by 93.72%
$24 Response to ASX Query re: Appendix 4C 2 May 2006 6:20PM $0.420 $0.017 fallen by 95.95%
$24 Commitments Test Entity - Third Quarter Report 27 Apr 2006 2:21PM $0.439 $0.017 fallen by 96.12%
$24 Results in recent feed additive trials for BDM-1 6 Apr 2006 10:36AM $0.495 $0.017 fallen by 96.56%
$24 Commences Clinical Trial for Diabetic Eye Disease 1 Mar 2006 11:58AM $0.681 $0.017 fallen by 97.50%
$24 Half Yearly Report 1 Mar 2006 9:16AM $0.681 $0.017 fallen by 97.50%
$24 Commitments Test Entity - Second Quarter Report 25 Jan 2006 4:12PM $0.602 $0.017 fallen by 97.18%
$24 Wins $2m AusIndustry Grant Award 21 Dec 2005 9:43AM $0.700 $0.017 fallen by 97.57%
$24 Clinical Trial in Diabetic Eye Disease 1 Dec 2005 12:35PM $0.625 $0.017 fallen by 97.28%
$24 BioDiem receives 3rd Milestone of US$1m for Flu Vaccine 29 Nov 2005 9:36AM $0.663 $0.017 fallen by 97.43%
$24 Commitments Test Entity - First Quarter Report 20 Oct 2005 4:02PM $0.761 $0.017 fallen by 97.76%
$24 Preliminary Final Report 25 Aug 2005 3:01PM $0.560 $0.017 fallen by 96.96%
$24 BioDiem receives 2nd milestone 29 Jul 2005 9:44AM $0.467 $0.017 fallen by 96.36%

426 - 450 of 458 results

Page 18 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.